Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Mark Yarchoan, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 294-311
Closed Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Supramolecular DNA Nanodevice Assembled via RCA and HCR Cascade Reaction on Tetrahedral DNA Nanostructure for Sensitive Detection and Intracellular Imaging of Dual-miRNAs Associated with Liver Cancer
Xue-Mei Zhou, Si–Yi Chen, Yaqin Chai, et al.
Analytical Chemistry (2025)
Closed Access
Downregulation of hnRNPA1 inhibits hepatocellular carcinoma cell progression by modulating alternative splicing of ZNF207 exon 9
Qi Ouyang, Wenhui He, Yiping Guo, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
A Dual‐Targeting Biomimetic Nanoplatform Integrates SDT/CDT/Gas Therapy to Boost Synergistic Ferroptosis for Orthotopic Hepatocellular Carcinoma Therapy
Wen Meng, Ting Chen, Xueping Li, et al.
Advanced Science (2025)
Open Access
Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access
Hepatocellular carcinoma: Revising the surgical approach in light of the concept of multiparametric therapeutic hierarchy
Umberto Cillo, Enrico Gringeri, F. DʼAmico, et al.
Digestive and Liver Disease (2025)
Closed Access
Invited Commentary: You May Delay, But Time Will Not
Fumihiro Kawano, Claudius Conrad
Journal of Gastrointestinal Surgery (2025), pp. 101970-101970
Closed Access
VCP downstream metabolite glycerol-3-phosphate (G3P) inhibits CD8+T cells function in the HCC microenvironment
Cheng Cheng, Qingrui Zha, Linmao Sun, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
TRIM29 reverses lenvatinib resistance in liver cancer cells by ubiquitinating and degrading YBX1 to inhibit the PI3K/AKT pathway
Yuhong Tang, Songsong Fan, Rui Peng, et al.
Translational Oncology (2025) Vol. 53, pp. 102294-102294
Closed Access
Self-assembling chemodrug fiber-hydrogel for transarterial chemoembolization and radiotherapy-enhanced antitumor immunity
Yisheng Peng, Hui Liu, Xiaoliu Liang, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 1-16
Closed Access
Invited Commentary: Hepatobiliary and Pancreatic Neoplasms: Predictive Imaging Meets Personalized Therapy
Maxime Ronot
Radiographics (2025) Vol. 45, Iss. 3
Closed Access
Minimalistic Implant for Percutaneous Magnetic Hyperthermia-Based Combination Therapy of Hepatocellular Carcinoma
Guangchao Xie, Bingjie Li, Shuyue Guo, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
A Ratio Luminescent Europium Organometallic Gel for In Vitro Detection of Hepatocellular Carcinoma Marker and Cellular Imaging
Xiao Lian, Fang Chen, Yanmin Zhang, et al.
Talanta (2025) Vol. 288, pp. 127708-127708
Closed Access
Therapeutic outcomes of thermal ablation versus repeated hepatic resection for recurrent hepatocellular carcinoma by using propensity score analysis: a multicenter real-world study
Ke Zhang, Wenbo Wang, Lei Mu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
KAT7-acetylated YBX1 promotes hepatocellular carcinoma proliferation by reprogramming nucleotide metabolism
He Huang, Longfei Ren, Yongqiang Zhou, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Polymeric Nanoparticles Simultaneously Delivering Paclitaxel Prodrug and Combretastatin A4 with Exceptionally High Drug Loading for Cancer Combination Therapy
Huicong Zhou, Zhaofan Yang, Guan-Yu Jin, et al.
Nano Letters (2025)
Closed Access
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors
Fei Du, Guojun Wang, Qian Dai, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Immunosenescence and immunotherapy in elderly patients with hepatocellular carcinoma
Dengyong Zhang, Yan Zhu, Zhengchao Shen, et al.
Seminars in Cancer Biology (2025) Vol. 111, pp. 60-75
Closed Access
Exploring the Role of Metabolic Hyperferritinaemia (MHF) in Steatotic Liver Disease (SLD) and Hepatocellular Carcinoma (HCC)
Nikolaos-Andreas Anastasopoulos, Alexandra Barbouti, Anna Goussia, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 842-842
Open Access
Comparison of efficacy and safety of adjuvant therapies versus sorafenib in hepatocellular carcinoma: a systematic review and network meta-analysis
Wenying Quan, Hanifah Fazlin Zulkifli, Nazamid Saari, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Construction of electrochemical immunosensor by integrating N, S doped carbon dots with Fe2O3 for ultrasensitive sensing alpha-fetoprotein
Yuzhuo Tuo, Rui Xu, Yawen Guan, et al.
Talanta (2025) Vol. 291, pp. 127887-127887
Closed Access
Neoadjuvant therapy for hepatocellular carcinoma—priming precision innovations to transform HCC treatment
Kristin E. Goodsell, Alice Tao, James O. Park
Frontiers in Surgery (2025) Vol. 12
Open Access
Naringenin: a potential therapeutic agent for modulating angiogenesis and immune response in hepatocellular carcinoma
Wenmei Wu, Xiangyu Qiu, Xiaofan Ye, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101254-101254
Open Access
LTA4H improves the tumor microenvironment and prevents HCC progression via targeting the HNRNPA1/LTBP1/TGF-β axis
Shuai Yang, Xinyao Qiu, Ying‐Cheng Yang, et al.
Cell Reports Medicine (2025), pp. 102000-102000
Open Access
5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation
Danjun Song, Zhou Zhang, Jiaping Zheng, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top